Key Factors to Accelerate Drug Discovery

A comprehensive drug development platform to integrate antibody engineering and antibody production technologies with extensive experience in services such as antibody sequencing and antibody humanization.

Microsystem-based screening method that harnesses the latest optofluidics technology, and combines the isolation, screening and evaluation of B cells on a chip, with the integration of high throughput platforms for assay screening.

GenScript's proprietary TurboCHO™ platform offers high throughput production of purified antibodies, featuring the market's fastest turnaround time—just 5 business days. With premium quality, this platform provides a cost-effective and time-efficient solution for antibody drug development research.